Sotera Health reported third-quarter 2026 net revenues of $324.9 million, up 4.4% from $311.3 million a year earlier, and net income of $58.4 million, or $0.20 per diluted share, compared with $48.4 million, or $0.17, in the prior-year quarter. The company reaffirmed its full-year 2026 constant currency revenue and Adjusted EBITDA growth outlook, which means shareholders see steady profit growth with no change to expectations.
Q3 2026 net revenues were $324.9 million, up 4.4% from $311.3 million in Q3 2025.
Q3 2026 Adjusted EPS was $0.29, up 12% from $0.26 per diluted share a year earlier.
Full-year 2026 outlook reaffirmed: net revenue growth of 5.25% to 6.75% and Adjusted EBITDA growth of 5.75% to 7.25%, both on a constant currency basis.
Net leverage ratio was 2.9x as of September 30, 2026, compared with 3.2x at December 31, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Sotera Health's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$1.16B
+5.7%
$0.27
+68.8%
6.7%
FY2024
$1.10B
+4.9%
$0.16
-11.1%
4.0%
FY2023
$1.05B
+4.5%
$0.18
—
4.9%
FY2022
$1.00B
+7.8%
$-0.83
-302.4%
-23.3%
FY2021
$931.48M
+13.9%
$0.41
—
12.5%
Frequently asked questions
When is Sotera Health's next earnings date?
Sotera Health has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Sotera Health earn last quarter?
For the quarter ended Sep 2026, Sotera Health reported diluted EPS of $0.20 (+17.6% year over year) on revenue of $324.89M (+4.4%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.